214 related articles for article (PubMed ID: 29980876)
1. Diagnostic accuracy of miRNAs as potential biomarkers for systemic lupus erythematosus: a meta-analysis.
Dai ZW; Wang H; Xu WJ; Wang ZH; Xu SQ; Wang B; Ye DQ
Clin Rheumatol; 2018 Nov; 37(11):2999-3007. PubMed ID: 29980876
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic significance of circulating miRNAs in systemic lupus erythematosus.
Zheng X; Zhang Y; Yue P; Liu L; Wang C; Zhou K; Hua Y; Wu G; Li Y
PLoS One; 2019; 14(6):e0217523. PubMed ID: 31163082
[TBL] [Abstract][Full Text] [Related]
3. A panel of circulating miRNAs as diagnostic biomarkers for screening multiple myeloma: a systematic review and meta-analysis.
Zhang L; Cao D; Tang L; Sun C; Hu Y
Int J Lab Hematol; 2016 Dec; 38(6):589-599. PubMed ID: 27870469
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic value of anti-citrullinated fibrinogen antibody in rheumatoid arthritis: A meta-analysis.
Dai ZW; Wang ZH; Dong YY; Wu Y; Wang HL; Wang DG; Wang B; Ye DQ
Int J Rheum Dis; 2019 Apr; 22(4):599-607. PubMed ID: 30729755
[TBL] [Abstract][Full Text] [Related]
5. Increased circulating CXCL13 levels in systemic lupus erythematosus and rheumatoid arthritis: a meta-analysis.
Bao YQ; Wang JP; Dai ZW; Mao YM; Wu J; Guo HS; Xia YR; Ye DQ
Clin Rheumatol; 2020 Jan; 39(1):281-290. PubMed ID: 31523787
[TBL] [Abstract][Full Text] [Related]
6. Blood-Based Circulating MicroRNAs are Potential Diagnostic Biomarkers for Leukemia: Result from a Meta-Analysis.
Xu LH; Guo Y; Zhang XL; Chen JJ; Hu SY
Cell Physiol Biochem; 2016; 38(3):939-49. PubMed ID: 26938054
[TBL] [Abstract][Full Text] [Related]
7. Significance of circRNAs as biomarkers for systemic lupus erythematosus: a systematic review and meta-analysis.
Wang L; Lu M; Li W; Fan R; Wen S; Xiao W; Lin Y
J Int Med Res; 2022 Jul; 50(7):3000605221103546. PubMed ID: 35796516
[TBL] [Abstract][Full Text] [Related]
8. [Accuracy of procalcitonin for diagnosis of sepsis in adults: a Meta-analysis].
Chengfen Y; Tong L; Xinjing G; Zhibo L; Lei X
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2015 Sep; 27(9):743-9. PubMed ID: 26955701
[TBL] [Abstract][Full Text] [Related]
9. Whole peripheral blood miR-146a and miR-155 expression levels in Systemic lupus erythematosus patients.
Shumnalieva R; Kachakova D; Shoumnalieva-Ivanova V; Miteva P; Kaneva R; Monov S
Acta Reumatol Port; 2018; 43(3):217-225. PubMed ID: 30414370
[TBL] [Abstract][Full Text] [Related]
10. A comprehensive meta-analysis of circulation miRNAs in glioma as potential diagnostic biomarker.
Ma C; Nguyen HPT; Luwor RB; Stylli SS; Gogos A; Paradiso L; Kaye AH; Morokoff AP
PLoS One; 2018; 13(2):e0189452. PubMed ID: 29444091
[TBL] [Abstract][Full Text] [Related]
11. MicroRNAs as Biomarkers for the Diagnostics of Bladder Cancer: a Meta-Analysis.
Chen L; Cui Z; Liu Y; Bai Y; Lan F
Clin Lab; 2015; 61(8):1101-8. PubMed ID: 26427157
[TBL] [Abstract][Full Text] [Related]
12. Association of the interleukin-10 gene polymorphism (-1082A/G) with systemic lupus erythematosus: a meta-analysis.
Zhou M; Ding L; Peng H; Wang B; Huang F; Xu WD; Li JH; Ye XR; Pan HF; Ye DQ
Lupus; 2013 Feb; 22(2):128-35. PubMed ID: 23192326
[TBL] [Abstract][Full Text] [Related]
13. Urine microRNAs as biomarkers for bladder cancer: a diagnostic meta-analysis.
Cheng Y; Deng X; Yang X; Li P; Zhang X; Li P; Tao J; Lu Q; Wang Z
Onco Targets Ther; 2015; 8():2089-96. PubMed ID: 26316777
[TBL] [Abstract][Full Text] [Related]
14. Are anti-nucleosome antibodies a better diagnostic marker than anti-dsDNA antibodies for systemic lupus erythematosus? A systematic review and a study of metanalysis.
Bizzaro N; Villalta D; Giavarina D; Tozzoli R
Autoimmun Rev; 2012 Dec; 12(2):97-106. PubMed ID: 22810055
[TBL] [Abstract][Full Text] [Related]
15. MicroRNAs as biomarkers for hepatocellular carcinoma: a diagnostic meta-analysis.
Hu QY; Jiang H; Su J; Jia YQ
Clin Lab; 2013; 59(9-10):1113-20. PubMed ID: 24273935
[TBL] [Abstract][Full Text] [Related]
16. High-Throughput Sequencing Reveals Circulating miRNAs as Potential Biomarkers of Kidney Damage in Patients with Systemic Lupus Erythematosus.
Navarro-Quiroz E; Pacheco-Lugo L; Lorenzi H; Díaz-Olmos Y; Almendrales L; Rico E; Navarro R; España-Puccini P; Iglesias A; Egea E; Aroca G
PLoS One; 2016; 11(11):e0166202. PubMed ID: 27835701
[TBL] [Abstract][Full Text] [Related]
17. The role of circulating microRNAs as novel biomarkers in diagnosing colorectal cancer: a meta-analysis.
Rokkas T; Kothonas F; Rokka A; Koukoulis G; Symvoulakis E
Eur J Gastroenterol Hepatol; 2015 Jul; 27(7):819-25. PubMed ID: 25856691
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic significance of microRNAs as novel biomarkers for bladder cancer: a meta-analysis of ten articles.
Shi HB; Yu JX; Yu JX; Feng Z; Zhang C; Li GY; Zhao RN; Yang XB
World J Surg Oncol; 2017 Aug; 15(1):147. PubMed ID: 28774300
[TBL] [Abstract][Full Text] [Related]
19. Circulating MicroRNAs as Potential Diagnostic Biomarkers for Diabetic Retinopathy: A Meta-Analysis.
Ma L; Wen Y; Li Z; Wu N; Wang Q
Front Endocrinol (Lausanne); 2022; 13():929924. PubMed ID: 35898469
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic and prognostic value of circulating miR-21 for cancer: a systematic review and meta-analysis.
Wang Y; Gao X; Wei F; Zhang X; Yu J; Zhao H; Sun Q; Yan F; Yan C; Li H; Ren X
Gene; 2014 Jan; 533(1):389-97. PubMed ID: 24076132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
